• Most Popular
  • Most Shared

Ipsen, Medicis submit botox product to FDA

Mon Mar 17, 2008 2:44am EDT

Stocks

   

PARIS, March 17 (Reuters) - French pharmaceutical group Ipsen (IPN.PA) and its U.S. partner Medicis (MRX.N) said on Monday they had submitted an application for a botox product to the U.S. Food & Drug Administration.

Stocks  |  Regulatory News

"Medicis and Ipsen today announced that Ipsen has submitted a Biologics License Application ("BLA") for the botulinum toxin type A, Reloxin(R)(1), in aesthetic indications (glabellar lines) to the U.S. Food & Drug Administration's division of dermatology and dental products," the companies said in a joint statement.

Ipsen shares closed at 38.25 euros on Friday while Medicis shares closed at $19.20. (Reporting by Sudip Kar-Gupta; Editing by Quentin Bryar)

Stocks
Regulatory News


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets